Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes
Sunil V. Rao(New York University), Robert A. Harrington(Clinical Research Institute), Kenneth W. Mahaffey(Cardiovascular Institute of the South), L. Kristin Newby(Duke University), Robert M. Califf(Duke University), Frans Van de Werf(KU Leuven), Karen S. Pieper(Clinical Research Institute), Kristi O’Grady(Clinical Research Institute), Christopher B. Granger(Clinical Research Institute)
Cited by 632
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k